| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Aug 24 | AGIO Agios Pharmaceuticals | Common stock | Option exercise | Acquire M | No | No | 0 | 2,302 | 0.00 | 7,992 |
| 11 Aug 24 | AGIO Agios Pharmaceuticals | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 2,302 | 0.00 | 2,302 |
| 20 Jun 24 | AGIO Agios Pharmaceuticals | Stock options Common stock | Grant | Acquire A | No | No | 42.45 | 11,774 | 499.81 k | 11,774 |
| 20 Jun 24 | AGIO Agios Pharmaceuticals | RSU Common stock | Grant | Acquire A | No | No | 0 | 2,120 | 0.00 | 2,120 |
| 13 Jun 24 | AGIO Agios Pharmaceuticals | Common stock | Option exercise | Acquire M | No | No | 0 | 3,388 | 0.00 | 5,690 |
| 13 Jun 24 | AGIO Agios Pharmaceuticals | RSU Common stock | Option exercise | Dispose M | No | No | 0 | 3,388 | 0.00 | 0 |
| 7 Jun 24 | TARA Protara Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.67 | 10,000 | 26.70 k | 10,000 |
| 6 Jun 24 | AKBA Akebia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 125,233 |
| 6 Jun 24 | AKBA Akebia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 45,000 | 48.15 k | 45,000 |
